InCerebro utilizes its MIND platform, which employs advanced modeling and AI techniques for in silico drug discovery, to create novel pharmaceuticals that have not been previously conceived. The company addresses the inefficiencies and limitations of traditional drug development processes by enabling rapid and precise identification of potential drug candidates.
Funding
Funding not disclosed
Founders
Product
Problem
Traditional drug discovery processes are inefficient and time-consuming, often failing to identify viable drug candidates due to limitations in modeling and experimental techniques. This results in high costs and prolonged timelines for bringing new pharmaceuticals to market.
Solution
InCerebro leverages its MIND platform, an advanced in silico drug discovery system, to design novel pharmaceuticals. The MIND platform employs sophisticated modeling and artificial intelligence techniques to rapidly and precisely identify potential drug candidates that may not be conceived through conventional methods. By simulating drug-target interactions and predicting efficacy, InCerebro aims to accelerate the drug development pipeline and reduce the reliance on resource-intensive laboratory experiments. The platform offers modules such as QM/MM Docking, Water Pharmacophore analysis, and AIMD (Ab Initio Molecular Dynamics) simulations for comprehensive drug design.
Target Audience
The primary target audience includes pharmaceutical companies and research institutions seeking to accelerate drug discovery and reduce development costs through advanced computational modeling and AI-driven insights.
Features
- MIND platform for in silico target modeling and drug discovery
- QM/MM Docking module for simulating drug-target interactions
- Water Pharmacophore analysis for identifying key water molecules in binding
- AIMD simulations for studying the structure of small proteins
- Globular AIMD for preparing and solvating globular proteins
- Membrane AIMD for preparing and solvating membrane-receptor complexes
- PPI AIMD platform for Protein-Protein Interaction analysis
- PROTAC AIMD for E3 ligase and target protein interaction studies
- MIND-BAR module for free energy calculations using implicit/explicit solvent